Literature DB >> 7875702

Serotonergic mechanisms in heart failure.

M Chandra1, V Gupta, A K Johri, R Misra, A Kumar, V Gujrati, K Shanker.   

Abstract

A total of 29 subjects were studied which included 18 heart failure and 11 matched control cases. The underlying heart disease in heart failure cases was mostly chronic rheumatic valvular disease. The diagnosis of heart disease and heart failure was made on the basis of clinical examination, supplemented by electrocardiography, chest skiagram and echo cardiography. The serotonin status was assessed by measuring platelet serotonin uptake, intraplatelet serotonin content and whole blood 5-hydroxytryptamine (5-HT) levels. Blood platelet count was also done. In heart failure cases, platelet count were significantly less, the platelet 5-HT uptake and blood 5-HT levels remain unaltered. These findings indicate that platelet pool of serotonin does not contribute to raised serotonin blood levels in heart failure. The high blood serotonin levels may be due to either clearance defect or enhanced secretion from the gut or both. The altered serotonin kinetics in platelets also indicate a state of platelet activation in heart failure.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7875702

Source DB:  PubMed          Journal:  Indian Heart J        ISSN: 0019-4832


  5 in total

Review 1.  New insights on receptor-dependent and monoamine oxidase-dependent effects of serotonin in the heart.

Authors:  J Mialet-Perez; P Bianchi; O Kunduzova; A Parini
Journal:  J Neural Transm (Vienna)       Date:  2007-04-30       Impact factor: 3.575

2.  5-HT4-elicited positive inotropic response is mediated by cAMP and regulated by PDE3 in failing rat and human cardiac ventricles.

Authors:  F Afzal; K W Andressen; H K Mørk; J M Aronsen; I Sjaastad; C P Dahl; T Skomedal; F O Levy; J-B Osnes; E Qvigstad
Journal:  Br J Pharmacol       Date:  2008-09-01       Impact factor: 8.739

3.  Functional serotonin 5-HT4 receptors in porcine and human ventricular myocardium with increased 5-HT4 mRNA in heart failure.

Authors:  Trond Brattelid; Eirik Qvigstad; James A Lynham; Peter Molenaar; Halfdan Aass; Odd Geiran; Tor Skomedal; Jan-Bjørn Osnes; Finn Olav Levy; Alberto J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-09-07       Impact factor: 3.000

4.  A xanthine-derivative K(+)-channel opener protects against serotonin-induced cardiomyocyte hypertrophy via the modulation of protein kinases.

Authors:  Hsuan-Fu Kuo; Yan-Jie Lai; Jung-Chou Wu; Kun-Tai Lee; Chih-Sheng Chu; Ing-Jun Chen; Jiunn-Ren Wu; Bin-Nan Wu
Journal:  Int J Biol Sci       Date:  2013-12-17       Impact factor: 6.580

5.  Influence of Serotonin 5-HT4 Receptors on Responses to Cardiac Stressors in Transgenic Mouse Models.

Authors:  Ulrich Gergs; Timo Gerigk; Jonas Wittschier; Constanze T Schmidbaur; Clara Röttger; Mareen Mahnkopf; Hanna Edler; Hartmut Wache; Joachim Neumann
Journal:  Biomedicines       Date:  2021-05-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.